
Patrick M. Buechner
Examiner (ID: 14872, Phone: (571)270-5171 , Office: P/3754 )
| Most Active Art Unit | 3754 |
| Art Unit(s) | 3799, 3754, OPQA |
| Total Applications | 1001 |
| Issued Applications | 780 |
| Pending Applications | 36 |
| Abandoned Applications | 187 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17343620
[patent_doc_number] => 20220009951
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-13
[patent_title] => TORSEMIDE PHOSPHATE PRODRUG, PREPARATION METHOD AND COMPOSITION THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/482827
[patent_app_country] => US
[patent_app_date] => 2021-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2533
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17482827
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/482827 | TORSEMIDE PHOSPHATE PRODRUG, PREPARATION METHOD AND COMPOSITION THEREOF | Sep 22, 2021 | Abandoned |
Array
(
[id] => 18752384
[patent_doc_number] => 20230355617
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-09
[patent_title] => SMALL MOLECULE INHIBITORS OF LEMUR TYROSINE KINASE 3
[patent_app_type] => utility
[patent_app_number] => 18/026054
[patent_app_country] => US
[patent_app_date] => 2021-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16416
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18026054
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/026054 | SMALL MOLECULE INHIBITORS OF LEMUR TYROSINE KINASE 3 | Sep 13, 2021 | Pending |
Array
(
[id] => 17335943
[patent_doc_number] => 20220002274
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-06
[patent_title] => 3,4,5-Trisubstituted-1,2,4-Triazoles and 3,4,5-Trisubstituted-3-Thio-1,2,4-Triazoles and Uses Thereof
[patent_app_type] => utility
[patent_app_number] => 17/466480
[patent_app_country] => US
[patent_app_date] => 2021-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39871
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 203
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17466480
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/466480 | 3,4,5-trisubstituted-1,2,4-triazoles and 3,4,5-trisubstituted-3-thio-1,2,4-triazoles and uses thereof | Sep 2, 2021 | Issued |
Array
(
[id] => 18597180
[patent_doc_number] => 20230271973
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-31
[patent_title] => BICYCLIC-HETEROCYCLE DERIVATIVES AND THEIR USES AS OREXIN-2 RECEPTOR AGONISTS
[patent_app_type] => utility
[patent_app_number] => 18/024216
[patent_app_country] => US
[patent_app_date] => 2021-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 92826
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18024216
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/024216 | Bicyclic-heterocycle derivatives and their uses as orexin-2 receptor agonists | Sep 2, 2021 | Issued |
Array
(
[id] => 18922834
[patent_doc_number] => 20240025838
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-25
[patent_title] => ESTER COMPOUND
[patent_app_type] => utility
[patent_app_number] => 18/022470
[patent_app_country] => US
[patent_app_date] => 2021-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44224
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 151
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18022470
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/022470 | ESTER COMPOUND | Aug 25, 2021 | Pending |
Array
(
[id] => 17578703
[patent_doc_number] => 20220135558
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-05
[patent_title] => ANTI-INFLUENZA VIRUS PYRIMIDINE DERIVATIVE
[patent_app_type] => utility
[patent_app_number] => 17/410801
[patent_app_country] => US
[patent_app_date] => 2021-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16408
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17410801
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/410801 | Anti-influenza virus pyrimidine derivative | Aug 23, 2021 | Issued |
Array
(
[id] => 18666244
[patent_doc_number] => 11773122
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-03
[patent_title] => Phospholipid compounds and uses thereof
[patent_app_type] => utility
[patent_app_number] => 17/409261
[patent_app_country] => US
[patent_app_date] => 2021-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 57524
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 242
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17409261
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/409261 | Phospholipid compounds and uses thereof | Aug 22, 2021 | Issued |
Array
(
[id] => 18861827
[patent_doc_number] => 20230416262
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-28
[patent_title] => TRPML MODULATORS
[patent_app_type] => utility
[patent_app_number] => 18/019638
[patent_app_country] => US
[patent_app_date] => 2021-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 65055
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18019638
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/019638 | TRPML MODULATORS | Aug 5, 2021 | Abandoned |
Array
(
[id] => 19013002
[patent_doc_number] => 11919917
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-03-05
[patent_title] => Sting agonistic compound
[patent_app_type] => utility
[patent_app_number] => 17/395643
[patent_app_country] => US
[patent_app_date] => 2021-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 25344
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17395643
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/395643 | Sting agonistic compound | Aug 5, 2021 | Issued |
Array
(
[id] => 18657577
[patent_doc_number] => 20230303484
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-28
[patent_title] => PRODUCTION OF DINITRILES
[patent_app_type] => utility
[patent_app_number] => 18/011532
[patent_app_country] => US
[patent_app_date] => 2021-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9400
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 120
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18011532
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/011532 | Production of dinitriles | Jul 29, 2021 | Issued |
Array
(
[id] => 20622563
[patent_doc_number] => 12590060
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-03-31
[patent_title] => Scalable synthetic route for psilocin and psilocybin
[patent_app_type] => utility
[patent_app_number] => 18/017197
[patent_app_country] => US
[patent_app_date] => 2021-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 10536
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18017197
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/017197 | Scalable synthetic route for psilocin and psilocybin | Jul 22, 2021 | Issued |
Array
(
[id] => 18825270
[patent_doc_number] => 11840540
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-12-12
[patent_title] => Dimers of covalent NFKB inhibitors
[patent_app_type] => utility
[patent_app_number] => 17/382083
[patent_app_country] => US
[patent_app_date] => 2021-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 7
[patent_no_of_words] => 11683
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 311
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17382083
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/382083 | Dimers of covalent NFKB inhibitors | Jul 20, 2021 | Issued |
Array
(
[id] => 20315988
[patent_doc_number] => 12454530
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-10-28
[patent_title] => Amido cyclohexane acid derivatives as LPA receptor inhibitors
[patent_app_type] => utility
[patent_app_number] => 18/015767
[patent_app_country] => US
[patent_app_date] => 2021-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22532
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 187
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18015767
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/015767 | Amido cyclohexane acid derivatives as LPA receptor inhibitors | Jul 14, 2021 | Issued |
Array
(
[id] => 17399495
[patent_doc_number] => 20220041585
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-10
[patent_title] => BROMOPHENOL-PYRAZOLINE COMPOUND AND SYNTHESIS METHOD AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/375635
[patent_app_country] => US
[patent_app_date] => 2021-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4048
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17375635
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/375635 | Bromophenol-pyrazoline compound and synthesis method and use thereof | Jul 13, 2021 | Issued |
Array
(
[id] => 17335924
[patent_doc_number] => 20220002255
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-06
[patent_title] => UBE2K MODULATORS AND METHODS FOR THEIR USE
[patent_app_type] => utility
[patent_app_number] => 17/369032
[patent_app_country] => US
[patent_app_date] => 2021-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22145
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17369032
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/369032 | UBE2K MODULATORS AND METHODS FOR THEIR USE | Jul 6, 2021 | Pending |
Array
(
[id] => 18443541
[patent_doc_number] => 11679092
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-06-20
[patent_title] => Prodrugs of fumarates and their use in treating various diseases
[patent_app_type] => utility
[patent_app_number] => 17/365199
[patent_app_country] => US
[patent_app_date] => 2021-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 20779
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17365199
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/365199 | Prodrugs of fumarates and their use in treating various diseases | Jun 30, 2021 | Issued |
Array
(
[id] => 19196384
[patent_doc_number] => 11993611
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-05-28
[patent_title] => Indolocarbazole analogs of staurosporine and methods of synthesis thereof
[patent_app_type] => utility
[patent_app_number] => 17/363370
[patent_app_country] => US
[patent_app_date] => 2021-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 16
[patent_no_of_words] => 7888
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17363370
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/363370 | Indolocarbazole analogs of staurosporine and methods of synthesis thereof | Jun 29, 2021 | Issued |
Array
(
[id] => 18575441
[patent_doc_number] => 11731953
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-08-22
[patent_title] => Methods and compounds for restoring mutant p53 function
[patent_app_type] => utility
[patent_app_number] => 17/354203
[patent_app_country] => US
[patent_app_date] => 2021-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 92160
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 324
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17354203
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/354203 | Methods and compounds for restoring mutant p53 function | Jun 21, 2021 | Issued |
Array
(
[id] => 19027285
[patent_doc_number] => 11926632
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-03-12
[patent_title] => Methods and compounds for restoring mutant p53 function
[patent_app_type] => utility
[patent_app_number] => 17/353199
[patent_app_country] => US
[patent_app_date] => 2021-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 116470
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 485
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17353199
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/353199 | Methods and compounds for restoring mutant p53 function | Jun 20, 2021 | Issued |
Array
(
[id] => 18497285
[patent_doc_number] => 20230219898
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-13
[patent_title] => COMPOUNDS AND METHODS FOR BLOCKING APOPTOSIS AND INDUCING AUTOPHAGY
[patent_app_type] => utility
[patent_app_number] => 18/010642
[patent_app_country] => US
[patent_app_date] => 2021-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27522
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18010642
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/010642 | COMPOUNDS AND METHODS FOR BLOCKING APOPTOSIS AND INDUCING AUTOPHAGY | Jun 15, 2021 | Pending |